Splice Bio is a Biotech company based in Barcelona, Spain. It has raised $170M in total funding. Latest round: Series B.
Splice Bio funding overview
Splice Bio is a Biotech company based in Barcelona, Spain. Splice Bio has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2025. The round record for Splice Bio runs through 2025; nothing later has been disclosed. Investors on record include EQT Life Sciences, Sanofi Ventures, Roche Venture Fund, New Enterprise Associates, UCB Ventures, Ysios Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Splice Bio at a glance
Total raised
$170M
Latest round
Series B
Latest round date
June 2025
Industry
Biotech
Headquarters
Barcelona, Spain
Notable investors
EQT Life Sciences, Sanofi Ventures, Roche Venture Fund, New Enterprise Associates, UCB Ventures, Ysios Capital, Gilde Healthcare, Novartis Venture Fund
Frequently asked about Splice Bio funding
How much has Splice Bio raised?
Splice Bio has raised $170M in total disclosed funding across the rounds on record.
Who has invested in Splice Bio?
EQT Life Sciences, Sanofi Ventures, Roche Venture Fund, New Enterprise Associates, UCB Ventures, Ysios Capital are named among the investors backing Splice Bio.
What was the latest Splice Bio funding round?
The most recent disclosed round is a Series B, announced in June 2025.
Where is Splice Bio based?
Splice Bio is based in Barcelona, Spain.
What sector does Splice Bio operate in?
Splice Bio is tracked under Biotech from Barcelona, Spain, with $170M in disclosed funding.
When did Splice Bio last raise?
The last disclosed Splice Bio round closed in June 2025 at Series B.
Every Splice Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Barcelona at a similar stage.
